| __timestamp | Bristol-Myers Squibb Company | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 189101000 |
| Thursday, January 1, 2015 | 5920000000 | 96351000 |
| Friday, January 1, 2016 | 4940000000 | 95967000 |
| Sunday, January 1, 2017 | 6411000000 | 112171000 |
| Monday, January 1, 2018 | 6345000000 | 182257000 |
| Tuesday, January 1, 2019 | 6148000000 | 336964000 |
| Wednesday, January 1, 2020 | 11143000000 | 547851000 |
| Friday, January 1, 2021 | 10195000000 | 693716000 |
| Saturday, January 1, 2022 | 9509000000 | 891813000 |
| Sunday, January 1, 2023 | 9299000000 | 1044071000 |
| Monday, January 1, 2024 | 11159000000 | 910408000 |
Unleashing insights
In the competitive world of pharmaceuticals, innovation is key to staying ahead. Bristol-Myers Squibb Company and Exelixis, Inc. have been at the forefront of this race, investing heavily in research and development (R&D) over the past decade. From 2014 to 2023, Bristol-Myers Squibb consistently outpaced Exelixis, with R&D expenses peaking in 2020 at over twice their 2014 levels. In contrast, Exelixis showed a steady increase, culminating in a 2023 investment that was more than five times their 2014 expenditure. This trend highlights Bristol-Myers Squibb's aggressive strategy, with R&D spending averaging around 18 times that of Exelixis annually. As the pharmaceutical landscape evolves, these investments underscore the companies' commitment to pioneering new treatments and maintaining their competitive edge.
Who Prioritizes Innovation? R&D Spending Compared for Amgen Inc. and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company vs Gilead Sciences, Inc.: Strategic Focus on R&D Spending
R&D Insights: How Bristol-Myers Squibb Company and Zoetis Inc. Allocate Funds
Bristol-Myers Squibb Company or BeiGene, Ltd.: Who Invests More in Innovation?
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Comparing Innovation Spending: Bristol-Myers Squibb Company and PTC Therapeutics, Inc.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Catalyst Pharmaceuticals, Inc.
Bristol-Myers Squibb Company vs Perrigo Company plc: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Vertex Pharmaceuticals Incorporated and Exelixis, Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs Exelixis, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Exelixis, Inc. and ACADIA Pharmaceuticals Inc.